Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

1.

Novel mechanism of antibody-independent complement neutralization of herpes simplex virus type 1.

Friedman HM, Wang L, Pangburn MK, Lambris JD, Lubinski J.

J Immunol. 2000 Oct 15;165(8):4528-36.

2.

Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.

Kostavasili I, Sahu A, Friedman HM, Eisenberg RJ, Cohen GH, Lambris JD.

J Immunol. 1997 Feb 15;158(4):1763-71.

PMID:
9029114
3.

The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway.

Hung SL, Peng C, Kostavasili I, Friedman HM, Lambris JD, Eisenberg RJ, Cohen GH.

Virology. 1994 Sep;203(2):299-312.

PMID:
8053154
4.
5.

Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein.

Huemer HP, Wang Y, Garred P, Koistinen V, Oppermann S.

Immunology. 1993 Aug;79(4):639-47.

6.

Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.

Friedman HM, Wang L, Fishman NO, Lambris JD, Eisenberg RJ, Cohen GH, Lubinski J.

J Virol. 1996 Jul;70(7):4253-60.

8.

Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.

Rux AH, Lou H, Lambris JD, Friedman HM, Eisenberg RJ, Cohen GH.

Virology. 2002 Mar 15;294(2):324-32.

9.

Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade.

Fries LF, Friedman HM, Cohen GH, Eisenberg RJ, Hammer CH, Frank MM.

J Immunol. 1986 Sep 1;137(5):1636-41.

PMID:
3018078
10.

Herpes simplex virus 1 ICP27 is required for transcription of two viral late (gamma 2) genes in infected cells.

Jean S, LeVan KM, Song B, Levine M, Knipe DM.

Virology. 2001 May 10;283(2):273-84.

11.

Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.

Beebe DP, Schreiber RD, Cooper NR.

J Immunol. 1983 Mar;130(3):1317-22.

PMID:
6822737
12.

In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC.

Lubinski J, Wang L, Mastellos D, Sahu A, Lambris JD, Friedman HM.

J Exp Med. 1999 Dec 6;190(11):1637-46. Erratum in: J Exp Med 2000 Feb 21;191(4):following 746.

13.

gp13 (EHV-gC): a complement receptor induced by equine herpesviruses.

Huemer HP, Nowotny N, Crabb BS, Meyer H, Hübert PH.

Virus Res. 1995 Jul;37(2):113-26.

PMID:
7483825
14.

Structure-function analysis of herpes simplex virus glycoprotein B with fusion-from-without activity.

Roller DG, Dollery SJ, Doyle JL, Nicola AV.

Virology. 2008 Dec 20;382(2):207-16. doi: 10.1016/j.virol.2008.09.015. Epub 2008 Oct 23.

15.
16.

Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine.

Awasthi S, Lubinski JM, Friedman HM.

Vaccine. 2009 Nov 16;27(49):6845-53. doi: 10.1016/j.vaccine.2009.09.017. Epub 2009 Sep 15.

17.

Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E.

Hook LM, Huang J, Jiang M, Hodinka R, Friedman HM.

J Virol. 2008 Jul;82(14):6935-41. doi: 10.1128/JVI.02599-07. Epub 2008 May 14.

18.
20.

Human lactoferrin but not lysozyme neutralizes HSV-1 and inhibits HSV-1 replication and cell-to-cell spread.

Välimaa H, Tenovuo J, Waris M, Hukkanen V.

Virol J. 2009 May 12;6:53. doi: 10.1186/1743-422X-6-53.

Supplemental Content

Support Center